MedPath

Measurement of yellow fever vaccine efficacy; is 10 years the right point in time for revaccination?

Completed
Conditions
Yellow fever infection
10047438
Registration Number
NL-OMON39667
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
119
Inclusion Criteria

> 18 years
having been administered a yellow fever vaccination

Exclusion Criteria

< 18 Years
Vaccination administered < 10 years prior

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The primary outcome measure is the proportion of volunteers who have 0.7 log10<br /><br>plaque<br /><br>reduction, as challenge experiments have shown this to correlate with<br /><br>protection.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Another outcome measure is the proportion of volunteers who have YF-17D-specific<br /><br>memory, as shown by the presence of YF-17D-specific cytokine producing CD8+ and<br /><br>CD4+ T cells.</p><br>
© Copyright 2025. All Rights Reserved by MedPath